The University of Southampton
University of Southampton Institutional Repository

Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data

Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data

OBJECTIVES: Most patients are unaware they have liver cirrhosis until they present with a decompensating event. We therefore aimed to develop and validate an algorithm to predict advanced liver disease (AdvLD) using data widely available in primary care.

DESIGN, SETTING AND PARTICIPANTS: Logistic regression was performed on routinely collected blood result data from the University Hospital Southampton (UHS) information systems for 16 967 individuals who underwent an upper gastrointestinal endoscopy (2005-2016). Data were used to create a model aimed at detecting AdvLD: 'CIRRhosis Using Standard tests' (CIRRUS). Prediction of a first serious liver event (SLE) was then validated in two cohorts of 394 253 (UHS: primary and secondary care) and 183 045 individuals (Care and Health Information Exchange (CHIE): primary care).

PRIMARY OUTCOME MEASURES: Model creation dataset: cirrhosis or portal hypertension. Validation datasets: SLE (gastro-oesophageal varices, liver-related ascites or cirrhosis).

RESULTS: In the model creation dataset, 931 SLEs were recorded (5.5%). CIRRUS detected cirrhosis or portal hypertension with an area under the curve (AUC) of 0.90 (95% CI 0.88 to 0.92). Overall, 3044 (0.8%) and 1170 (0.6%) SLEs were recorded in the UHS and CHIE validation cohorts, respectively. In the UHS cohort, CIRRUS predicted a first SLE within 5 years with an AUC of 0.90 (0.89 to 0.91) continuous, 0.88 (0.87 to 0.89) categorised (crimson, red, amber, green grades); and AUC 0.84 (0.82 to 0.86) and 0.83 (0.81 to 0.85) for the CHIE cohort. In patients with a specified liver risk factor (alcohol, diabetes, viral hepatitis), a crimson/red cut-off predicted a first SLE with a sensitivity of 72%/59%, specificity 87%/93%, positive predictive value 26%/18% and negative predictive value 98%/99% for the UHS/CHIE validation cohorts, respectively.

CONCLUSION: Identification of individuals at risk of AdvLD within primary care using routinely available data may provide an opportunity for earlier intervention and prevention of liver-related morbidity and mortality.

Esophageal and Gastric Varices/diagnosis, Hematologic Tests, Humans, Liver Cirrhosis/diagnosis, Secondary Care, United Kingdom/epidemiology
2044-6055
e044952
Hydes, Theresa
d842d1ec-c64a-4934-a5a2-7316fea65767
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Stuart, Beth
626862fc-892b-4f6d-9cbb-7a8d7172b209
Kim, Miranda
c2e4ad50-0a64-4da9-8335-78531d88e93d
Su, Fangzhong
38102373-9952-4599-8657-530d44359cd8
Newell, Colin
fd859e4b-b3a6-4722-b1de-2e52c8633899
Cable, David
4e0028d3-0340-4f02-8a8c-7be8d66f636b
Hales, Alan
66a20906-7b0e-4d23-b65a-08932f23900b
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1
Hydes, Theresa
d842d1ec-c64a-4934-a5a2-7316fea65767
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Stuart, Beth
626862fc-892b-4f6d-9cbb-7a8d7172b209
Kim, Miranda
c2e4ad50-0a64-4da9-8335-78531d88e93d
Su, Fangzhong
38102373-9952-4599-8657-530d44359cd8
Newell, Colin
fd859e4b-b3a6-4722-b1de-2e52c8633899
Cable, David
4e0028d3-0340-4f02-8a8c-7be8d66f636b
Hales, Alan
66a20906-7b0e-4d23-b65a-08932f23900b
Sheron, Nick
cbf852e3-cfaa-43b2-ab99-a954d96069f1

Hydes, Theresa, Moore, Michael, Stuart, Beth, Kim, Miranda, Su, Fangzhong, Newell, Colin, Cable, David, Hales, Alan and Sheron, Nick (2021) Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data. BMJ Open, 11 (2), e044952, [e044952]. (doi:10.1136/bmjopen-2020-044952).

Record type: Article

Abstract

OBJECTIVES: Most patients are unaware they have liver cirrhosis until they present with a decompensating event. We therefore aimed to develop and validate an algorithm to predict advanced liver disease (AdvLD) using data widely available in primary care.

DESIGN, SETTING AND PARTICIPANTS: Logistic regression was performed on routinely collected blood result data from the University Hospital Southampton (UHS) information systems for 16 967 individuals who underwent an upper gastrointestinal endoscopy (2005-2016). Data were used to create a model aimed at detecting AdvLD: 'CIRRhosis Using Standard tests' (CIRRUS). Prediction of a first serious liver event (SLE) was then validated in two cohorts of 394 253 (UHS: primary and secondary care) and 183 045 individuals (Care and Health Information Exchange (CHIE): primary care).

PRIMARY OUTCOME MEASURES: Model creation dataset: cirrhosis or portal hypertension. Validation datasets: SLE (gastro-oesophageal varices, liver-related ascites or cirrhosis).

RESULTS: In the model creation dataset, 931 SLEs were recorded (5.5%). CIRRUS detected cirrhosis or portal hypertension with an area under the curve (AUC) of 0.90 (95% CI 0.88 to 0.92). Overall, 3044 (0.8%) and 1170 (0.6%) SLEs were recorded in the UHS and CHIE validation cohorts, respectively. In the UHS cohort, CIRRUS predicted a first SLE within 5 years with an AUC of 0.90 (0.89 to 0.91) continuous, 0.88 (0.87 to 0.89) categorised (crimson, red, amber, green grades); and AUC 0.84 (0.82 to 0.86) and 0.83 (0.81 to 0.85) for the CHIE cohort. In patients with a specified liver risk factor (alcohol, diabetes, viral hepatitis), a crimson/red cut-off predicted a first SLE with a sensitivity of 72%/59%, specificity 87%/93%, positive predictive value 26%/18% and negative predictive value 98%/99% for the UHS/CHIE validation cohorts, respectively.

CONCLUSION: Identification of individuals at risk of AdvLD within primary care using routinely available data may provide an opportunity for earlier intervention and prevention of liver-related morbidity and mortality.

Text
e044952.full - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 6 January 2021
e-pub ahead of print date: 11 February 2021
Published date: 11 February 2021
Keywords: Esophageal and Gastric Varices/diagnosis, Hematologic Tests, Humans, Liver Cirrhosis/diagnosis, Secondary Care, United Kingdom/epidemiology

Identifiers

Local EPrints ID: 450430
URI: http://eprints.soton.ac.uk/id/eprint/450430
ISSN: 2044-6055
PURE UUID: f7a21940-56dc-4d8c-ae70-bae051c52c42
ORCID for Michael Moore: ORCID iD orcid.org/0000-0002-5127-4509
ORCID for Beth Stuart: ORCID iD orcid.org/0000-0001-5432-7437
ORCID for Nick Sheron: ORCID iD orcid.org/0000-0001-5232-8292

Catalogue record

Date deposited: 28 Jul 2021 16:30
Last modified: 18 Mar 2024 03:04

Export record

Altmetrics

Contributors

Author: Theresa Hydes
Author: Michael Moore ORCID iD
Author: Beth Stuart ORCID iD
Author: Miranda Kim
Author: Fangzhong Su
Author: Colin Newell
Author: David Cable
Author: Alan Hales
Author: Nick Sheron ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×